Stock Taper 
DAFNA CAPITAL MANAGEMENT LLC
Latest 13F filing data - Q2 2026
Holdings
(Top positions)| STOCK | TICKER | SHARES HELD▲ ▼ | VALUE▲ ▼ |
|---|---|---|---|
 COMPASS Pathways plc | CMPS | 2.01M | $28.47M |
 Allogene Therapeutics, Inc. | ALLO | 2M | $4.16M |
 Accuray Incorporated | ARAY | 1.68M | $433.24K |
 Inogen, Inc. | INGN | 845.18K | $5.45M |
 Denali Therapeutics Inc. | DNLI | 739.01K | $19.01M |
 Aquestive Therapeutics, Inc. | AQST | 645.91K | $2.69M |
 AtriCure, Inc. | ATRC | 597.43K | $16.72M |
 Revolution Medicines, Inc. | RVMD | 562.63K | $105.37M |
 Fate Therapeutics, Inc. | FATE | 525K | $1.42M |
 IDEAYA Biosciences, Inc. | IDYA | 497.24K | $18.53M |
 Arcus Biosciences, Inc. | RCUS | 441.83K | $13.62M |
 BioCryst Pharmaceuticals, Inc. | BCRX | 400.25K | $4M |
 Tandem Diabetes Care, Inc. | TNDM | 355.21K | $5.36M |
 Syndax Pharmaceuticals, Inc. | SNDX | 335.25K | $7.33M |
 Nektar Therapeutics | NKTR | 318.38K | $22.23M |
 Bicara Therapeutics Inc. Common Stock | BCAX | 284.95K | $8.46M |
 Xenon Pharmaceuticals Inc. | XENE | 250.77K | $15.14M |
 Edgewise Therapeutics, Inc. | EWTX | 226.82K | $9.22M |
 AxoGen, Inc. | AXGN | 208.96K | $9.65M |
 OrthoPediatrics Corp. | KIDS | 189.13K | $3.62M |